Cloning and characterization of a novel human DNase (Q24308800)

GOA release 2020-03-11

DNA metabolic process

1 reference

GOA release 2020-03-11

author name string

Z Zeng

1

0 references

D Parmelee

2

0 references

H Hyaw

3

0 references

T A Coleman

4

0 references

K Su

5

0 references

J Zhang

6

0 references

R Gentz

7

0 references

S Ruben

8

0 references

C Rosen

9

0 references

Y Li

Biochemical and Biophysical Research Communications

10

0 references

language of work or name

English

0 references

publication date

13 February 1997

0 references

published in

0 references

volume

231

0 references

page(s)

499-504

0 references

issue

2

0 references

cites work

DNA recognition by DNase I.

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

DNA structural variations in the E. coli tyrT promoter

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Sequence identification of 2,375 human brain genes

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Actin is the naturally occurring inhibitor of deoxyribonuclease I

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Engineering actin-resistant human DNase I for treatment of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Complementary DNA sequencing: expressed sequence tags and human genome project

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Expression cloning and signaling properties of the rat glucagon receptor

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1996.5923

7 January 2021